This arose from FH mutations and antibodies in aHUS, albeit patients with a low FH level were also present in STEC-HUS, secondary TMA and TTP, indicating the presence of complement dysregulation in multiple forms of TMA. Here, FH is linked to thrombotic thrombocytopenic purpura.